Mahoney Michael F insider trades
Mahoney Michael F has filed 57 Form 4s with the SEC that we hold, for Boston Scientific Corp (BSX) (Chairman, President & CEO, Director), CVS HEALTH Corp (CVS) (Director) and Baxter International INC (BAX) (Director). Across all of them we count 3 purchases worth $11.5M and 25 sales worth $188.8M reported on Form 4. In the last 12 months: 1 purchase ($9.0M) and 2 sales ($15.0M). The largest single trade was a sale of 164,442 shares of Boston Scientific Corp worth $16.4M, dated 2025-04-01. The first filing on our record is dated 2021-07-08 and the latest 2026-08-05.
Boston Scientific Corp (BSX)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-07-06 | S, sale reported on Form 4 | 201,041 | $8.7M | 2021-07-08 |
| 2021-08-02 | S, sale reported on Form 4 | 201,043 | $9.2M | 2021-08-04 |
| 2021-09-07 | S, sale reported on Form 4 | 201,041 | $9.0M | 2021-09-08 |
| 2021-10-04 | S, sale reported on Form 4 | 97,838 | $4.2M | 2021-10-05 |
| 2021-10-04 | S, sale reported on Form 4 | 103,204 | $4.5M | 2021-10-05 |
| 2021-11-01 | S, sale reported on Form 4 | 201,042 | $8.7M | 2021-11-02 |
| 2022-08-08 | S, sale reported on Form 4 | 125,828 | $5.2M | 2022-08-09 |
| 2022-09-06 | S, sale reported on Form 4 | 125,828 | $5.1M | 2022-09-07 |
| 2022-10-03 | S, sale reported on Form 4 | 125,827 | $5.0M | 2022-10-04 |
| 2022-11-07 | S, sale reported on Form 4 | 125,827 | $5.3M | 2022-11-08 |
| 2023-09-12 | S, sale reported on Form 4 | 113,355 | $6.1M | 2023-09-12 |
| 2023-10-09 | S, sale reported on Form 4 | 113,355 | $5.9M | 2023-10-10 |
| 2023-11-06 | S, sale reported on Form 4 | 113,356 | $6.0M | 2023-11-07 |
| 2024-09-05 | S, sale reported on Form 4 | 162,777 | $13.2M | 2024-09-06 |
| 2024-10-07 | S, sale reported on Form 4 | 80,692 | $6.8M | 2024-10-08 |
| 2024-10-07 | S, sale reported on Form 4 | 82,085 | $7.0M | 2024-10-08 |
| 2024-11-05 | S, sale reported on Form 4 | 160,182 | $13.6M | 2024-11-07 |
| 2024-11-05 | S, sale reported on Form 4 | 2,596 | $221.1K | 2024-11-07 |
| 2025-04-01 | S, sale reported on Form 4 | 164,442 | $16.4M | 2025-04-02 |
| 2025-05-01 | S, sale reported on Form 4 | 91,282 | $9.3M | 2025-05-05 |
| 2025-05-01 | S, sale reported on Form 4 | 73,161 | $7.5M | 2025-05-05 |
| 2025-06-02 | S, sale reported on Form 4 | 89,921 | $9.3M | 2025-06-03 |
| 2025-06-02 | S, sale reported on Form 4 | 74,522 | $7.8M | 2025-06-03 |
| 2026-02-02 | S, sale reported on Form 4 | 159,701 | $14.9M | 2026-02-03 |
| 2026-02-02 | S, sale reported on Form 4 | 1,200 | $112.9K | 2026-02-03 |
| 2026-08-03 | P, purchase reported on Form 4 | 186,240 | $9.0M | 2026-08-05 |
CVS HEALTH Corp (CVS)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2024-05-02 | P, purchase reported on Form 4 | 9,181 | $500.3K | 2024-05-02 |
| 2025-02-18 | P, purchase reported on Form 4 | 30,000 | $2.0M | 2025-02-19 |
Baxter International INC (BAX)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1533022) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms